ArcticZymes Technologies 미래 성장

Future 기준 확인 4/6

ArcticZymes Technologies (는) 각각 연간 73.8% 및 14.2% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 74.5% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 2.5% 로 예상됩니다.

주요 정보

73.8%

수익 성장률

74.5%

EPS 성장률

Biotechs 수익 성장	16.4%
매출 성장률	14.2%
향후 자기자본 수익률	2.5%
애널리스트 커버리지	Low
마지막 업데이트	09 Dec 2024

최근 미래 성장 업데이트

ArcticZymes Technologies ASA Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Nov 09

Recent updates

Take Care Before Jumping Onto ArcticZymes Technologies ASA (OB:AZT) Even Though It's 25% Cheaper

Nov 28

Analysts Are More Bearish On ArcticZymes Technologies ASA (OB:AZT) Than They Used To Be

Nov 12

ArcticZymes Technologies ASA Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Nov 09

The Price Is Right For ArcticZymes Technologies ASA (OB:AZT) Even After Diving 28%

Aug 31

ArcticZymes Technologies' (OB:AZT) Solid Earnings May Rest On Weak Foundations

Aug 30

ArcticZymes Technologies ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 25

Earnings Miss: ArcticZymes Technologies ASA Missed EPS By 17% And Analysts Are Revising Their Forecasts

May 12

ArcticZymes Technologies' (OB:AZT) Shareholders Have More To Worry About Than Only Soft Earnings

Feb 08

ArcticZymes Technologies ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 04

Investors Aren't Buying ArcticZymes Technologies ASA's (OB:AZT) Revenues

Feb 02

ArcticZymes Technologies ASA's (OB:AZT) Sole Analyst Just Made A Substantial Upgrade To Their Forecasts

Apr 29

Downgrade: Here's How This Analyst Sees ArcticZymes Technologies ASA (OB:AZT) Performing In The Near Term

Apr 15

One Analyst Just Shaved Their ArcticZymes Technologies ASA (OB:AZT) Forecasts Dramatically

Jan 13

Here's What Analysts Are Forecasting For ArcticZymes Technologies ASA (OB:AZT) After Its First-Quarter Results

May 01

수익 및 매출 성장 예측

OB:AZT - 애널리스트의 미래 추정치 및 과거 재무 데이터 (NOK Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	147	21	15	29	2
12/31/2025	123	8	5	17	2
12/31/2024	106	4	-14	-3	2
9/30/2024	111	5	-8	7	N/A
6/30/2024	118	15	0	20	N/A
3/31/2024	118	18	7	28	N/A
12/31/2023	120	19	5	24	N/A
9/30/2023	119	20	7	27	N/A
6/30/2023	118	16	8	25	N/A
3/31/2023	120	17	20	36	N/A
12/31/2022	138	33	46	58	N/A
9/30/2022	150	47	56	64	N/A
6/30/2022	147	52	58	68	N/A
3/31/2022	139	48	55	65	N/A
12/31/2021	131	46	63	75	N/A
9/30/2021	114	68	54	64	N/A
6/30/2021	108	67	57	61	N/A
3/31/2021	120	84	63	66	N/A
12/31/2020	98	74	45	47	N/A
9/30/2020	64	43	48	50	N/A
6/30/2020	68	37	37	39	N/A
3/31/2020	88	8	10	12	N/A
12/31/2019	49	-1	3	4	N/A
9/30/2019	80	-9	-3	-1	N/A
6/30/2019	79	-10	-11	-9	N/A
3/31/2019	73	-13	-10	-7	N/A
12/31/2018	73	-14	-18	-15	N/A
9/30/2018	70	-20	-25	-22	N/A
6/30/2018	63	-27	N/A	-21	N/A
3/31/2018	69	-27	N/A	-23	N/A
12/31/2017	73	-25	N/A	-22	N/A
9/30/2017	74	-26	N/A	-23	N/A
6/30/2017	80	-24	N/A	-22	N/A
3/31/2017	79	-21	N/A	-18	N/A
12/31/2016	79	-20	N/A	-19	N/A
9/30/2016	78	-20	N/A	-14	N/A
6/30/2016	72	-19	N/A	-13	N/A
3/31/2016	66	-18	N/A	-14	N/A
12/31/2015	59	-17	N/A	-13	N/A
9/30/2015	55	-15	N/A	-14	N/A
6/30/2015	48	-16	N/A	-17	N/A
3/31/2015	46	-18	N/A	-20	N/A
12/31/2014	38	-22	N/A	-21	N/A
9/30/2014	34	-23	N/A	-23	N/A
6/30/2014	31	-21	N/A	-26	N/A
3/31/2014	26	-24	N/A	-21	N/A
12/31/2013	28	-23	N/A	-17	N/A

애널리스트 미래 성장 예측

수입 대 저축률: AZT 의 연간 예상 수익 증가율( 73.8% )이 saving rate( 2.4% 보다 높습니다. ).

수익 vs 시장: AZT 의 연간 수익( 73.8% ) Norwegian 시장( 9.5% 보다 빠르게 성장할 것으로 예상됩니다. 9.5% 연간).

고성장 수익: AZT 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: AZT 의 수익(연간 14.2% ) Norwegian 시장( 2.2% 보다 빠르게 성장할 것으로 예상됩니다. 2.2% 연간).

고성장 수익: AZT 의 수익(연간 14.2% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: AZT 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 2.5 %).

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2024/12/19 05:15
장 마감 주가	2024/12/19 00:00
수익	2024/09/30
연간 수익	2023/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

ArcticZymes Technologies ASA 8 애널리스트 중 2 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Hans Bohn	Beringer Finance AB
Mikkel Nyholt-Smedseng	Carnegie Investment Bank AB
Espen Jørgensen	DNB Markets

ArcticZymes Technologies 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

Consensus EPS estimates fall by 48%

Consensus EPS estimates increase by 93%

Consensus EPS estimates fall by 70%

ArcticZymes Technologies ASA Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Consensus EPS estimates fall by 19%

Consensus EPS estimates fall by 21%

Recent updates

ArcticZymes Technologies ASA Expands San HQ Portfolio with Two Advanced Solutions Tailored for Cell, Gene and Vaccine Biomanufacturers

ArcticZymes Technologies ASA, Annual General Meeting, May 27, 2025

ArcticZymes Technologies ASA to Report Q1, 2025 Results on May 08, 2025

Consensus EPS estimates fall by 48%

Take Care Before Jumping Onto ArcticZymes Technologies ASA (OB:AZT) Even Though It's 25% Cheaper

Consensus EPS estimates increase by 93%

Consensus EPS estimates fall by 70%

Analysts Are More Bearish On ArcticZymes Technologies ASA (OB:AZT) Than They Used To Be

Chief Executive Officer recently bought kr102k worth of stock

ArcticZymes Technologies ASA Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

Consensus EPS estimates fall by 19%

The Price Is Right For ArcticZymes Technologies ASA (OB:AZT) Even After Diving 28%

ArcticZymes Technologies' (OB:AZT) Solid Earnings May Rest On Weak Foundations

Consensus EPS estimates fall by 21%

New minor risk - Market cap size

New major risk - Earnings quality

ArcticZymes Technologies ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

ArcticZymes Technologies ASA Announces the Appointment of Frank Mathias as Chairman of the Board of Directors

New major risk - Earnings quality

Less than half of directors are independent

ArcticZymes Technologies ASA Announces Board Resignations

Earnings Miss: ArcticZymes Technologies ASA Missed EPS By 17% And Analysts Are Revising Their Forecasts

Price target decreased by 24% to kr25.00

First quarter 2024 earnings: Revenues in line with analyst expectations

ArcticZymes Technologies ASA Announces Resignation of Edgar Koster as Board Member

ArcticZymes Technologies' (OB:AZT) Shareholders Have More To Worry About Than Only Soft Earnings

Consensus revenue estimates fall by 14%

New major risk - Earnings quality

ArcticZymes Technologies ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Price target decreased by 8.6% to kr32.00

Investors Aren't Buying ArcticZymes Technologies ASA's (OB:AZT) Revenues

Full year 2023 earnings: EPS and revenues miss analyst expectations

Arcticzymes Technologies Asa Announces the Launch of Its First Gmp-Grade Product, San Hq

ArcticZymes Technologies ASA Launches T7 RNA Polymerase

ArcticZymes Technologies ASA, Annual General Meeting, Jun 05, 2024

Consensus EPS estimates increase by 128%

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

ArcticZymes Technologies ASA Announces DMF for SAN HQ GMP accepted by the US FDA

Consensus EPS estimates fall by 57%

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

ArcticZymes Technologies ASA Appoints Michael Akoh as Chief Executive Officer, Will Commence His Position No Later Than 1 November 2023

Chief Financial Officer exercised options and sold kr4.2m worth of stock

First quarter 2023 earnings: EPS and revenues miss analyst expectations

ArcticZymes Technologies ASA's (OB:AZT) Sole Analyst Just Made A Substantial Upgrade To Their Forecasts

Consensus revenue estimates increase by 11%

Consensus revenue estimates increase by 11%

Downgrade: Here's How This Analyst Sees ArcticZymes Technologies ASA (OB:AZT) Performing In The Near Term

Consensus revenue estimates fall by 10%

Consensus EPS estimates fall by 25%

Director recently bought kr426k worth of stock

Full year 2022 earnings: EPS misses analyst expectations

Consensus revenue estimates fall by 12%

One Analyst Just Shaved Their ArcticZymes Technologies ASA (OB:AZT) Forecasts Dramatically

Consensus revenue estimates fall by 12%

Investor sentiment deteriorated over the past week

ArcticZymes Technologies Launches SAN HQ 2.0 ELISA kit

ArcticZymes Technologies ASA Appoints Darren Ellis as Chief Scientific Officer

ArcticZymes Technologies ASA to Report Q4, 2022 Results on Feb 02, 2023

Consensus EPS estimates fall by 21%

Consensus EPS estimates fall by 21%

Consensus EPS estimates fall by 21%

Consensus EPS estimates increase by 26%

No independent directors

Consensus forecasts updated

Third quarter 2022 earnings: EPS and revenues miss analyst expectations